Notícias
Statement on FTC Win Securing Temporary Block of IQVIA’s Acquisition of Propel Media
Tags:
The U.S. District Court for the Southern District of New York granted on December 29, 2023, the Federal Trade Commission’s request for a preliminary injunction to prevent IQVIA Holdings Inc. (IQVIA) from acquiring Propel Media, Inc. pending the Commission’s administrative proceeding seeking to permanently block the proposed deal.
In response, Bureau of Competition Director Henry Liu issued the following statement:
“To close out 2023, the FTC secured another significant victory that temporarily blocks an anticompetitive merger that would raise health care prices for consumers. The federal court’s order in IQVIA is also a win for the FTC as it continues to challenge anticompetitive deals involving health care and emerging technology platforms. We are pleased with the federal court’s decision and look forward to continuing to fight to permanently enjoin this anticompetitive deal via the Commission’s administrative proceedings.
Congratulations to the Mergers I Division on this important initial victory and thank you to all the staff who worked on this case.”
On July 17, 2023, the FTC sued to block IQVIA’s acquisition of Propel Media alleging in an administrative complaint that the proposed acquisition would give IQVIA a market-leading position in programmatic advertising targeted to doctors and other health care professionals. The Commission also authorized FTC staff to seek a temporary restraining order and preliminary injunction in federal district court to prevent IQVIA from consummating its acquisition of Propel Media, pending the agency’s administrative proceeding.
After a nearly two-week evidentiary hearing and closing arguments in late November and December 2023, U.S. District Court Judge Edgardo Ramos issued an order granting the FTC’s motion for preliminary injunction on December 29, 2023. The administrative trial is scheduled to begin on January 18, 2024.
The IQVIA federal court order is the fourth merger victory for the FTC in less than a month as the Commission seeks lower health care costs by preventing anticompetitive deals. In December 2023, the FTC also secured victories in its challenges against Illumina’s acquisition of Grail, John Muir’s takeover of San Ramon Regional Medical Center from Tenet Healthcare, and Sanofi’s acquisition of Maze Therapeutics’ Pompe disease drug. The IQVIA order also comes several weeks after the FTC’s successful challenge of several drug products as improperly or inaccurately listed in the Food and Drug Administration’s Orange Book.
The Federal Trade Commission works to promote competition, and protect and educate consumers. You can learn more about how competition benefits consumers or file an antitrust complaint. For the latest news and resources, follow the FTC on social media, subscribe to press releases and read our blog.
Press Release Reference
Contact Information
Media Contact
Office of Public Affairs
Whistleblower statistics 2022 to 2023
The number of disclosures received between 1 April 2022 and 31 March 2023 which we reasonably believe are ‘qualifying disclosures’ and the action taken for each case.From:Competition and Markets AuthorityPublished4 January 2024Get emails about this page
Documents
Whistleblowing statistics: 2022 to 2023
HTML
Details
The CMA is a listed organisation included in the Prescribed Persons Order 2014, which provides the statutory framework for protecting persons from harm if they report on any wrongdoing involving their employer. The process by which a person may make this report is referred to as “making a disclosure” or “whistleblowing”.
To be covered by whistleblowing law, the disclosure must be a ‘qualifying disclosure’. This is any disclosure of information which, in the reasonable belief of the worker making the disclosure, is made in the public interest and tends to show that one or more of the following has occurred, is occurring or is likely to occur:
- a criminal offence (this may include, for example, types of financial impropriety such as fraud)
- a breach of a legal obligation
- a miscarriage of justice
- danger to the health or safety of any individual
- damage to the environment
- the deliberate covering up of wrongdoing in the above categories
More information can be found in Whistleblowing: guidance for prescribed persons.
Published 4 January 2024
Casos
FTC
IQVIA Holdings/Propel Media, In the Matter of
On July 17, 2023, the Federal Trade Commission sued to block IQVIA Holdings Inc. (IQVIA) from acquiring Propel Media, Inc. (PMI), alleging in an administrative complaint that the proposed acquisition would give IQVIA a market- leading position in programmatic advertising for health care products, namely prescription drugs, to doctors and other health care professionals. The Commission also authorized FTC staff to seek a temporary restraining order and preliminary injunction in federal district court to prevent IQVIA from consummating its acquisition of PMI, pending the agency’s administrative proceeding.
After a nearly two-week evidentiary hearing and closing arguments in late November and December 2023, U.S. District Court Judge Edgardo Ramos issued an order granting the FTC’s motion for preliminary injunction on December 29, 2023.
Type of Action
Administrative
Last Updated
January 3, 2024
FTC Matter/File Number
2210196
Docket Number
9416
Case Status
Pending